HC Wainwright Increases Earnings Estimates for electroCore

electroCore, Inc. (NASDAQ:ECOR) – Stock analysts at HC Wainwright upped their FY2026 earnings per share (EPS) estimates for electroCore in a research note issued on Wednesday, December 18th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of $0.52 for the year, up from their prior forecast of $0.43. HC Wainwright currently has a “Buy” rating and a $25.00 price target on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s FY2027 earnings at $1.34 EPS and FY2028 earnings at $2.24 EPS.

electroCore Trading Down 6.1 %

electroCore stock opened at $14.52 on Thursday. The stock has a 50 day moving average of $11.51 and a two-hundred day moving average of $8.12. electroCore has a twelve month low of $5.25 and a twelve month high of $17.84. The stock has a market capitalization of $95.18 million, a price-to-earnings ratio of -7.93 and a beta of 0.57.

Institutional Investors Weigh In On electroCore

Several hedge funds have recently modified their holdings of the stock. HighTower Advisors LLC acquired a new position in electroCore in the 3rd quarter valued at $255,000. International Assets Investment Management LLC lifted its stake in shares of electroCore by 27.9% in the 2nd quarter. International Assets Investment Management LLC now owns 67,820 shares of the company’s stock worth $436,000 after acquiring an additional 14,800 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of electroCore by 3.4% in the second quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock valued at $442,000 after acquiring an additional 2,270 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of electroCore by 10.3% during the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares during the period. 26.74% of the stock is owned by institutional investors and hedge funds.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.